Marks: COVID-19 Vaccine EUA-Plus Not New, Guide Hikes Transparency

By Kelly Lienhard / September 30, 2020 at 7:30 PM
FDA biologics center director Peter Marks doubled down on the agency’s stance that its emergency use authorization guidance, hung up at the White House, simply lays out stricter criteria for potential COVID-19 vaccines that industry has been aware of for months, despite suggestions from the White House that the guidance is a political ploy. Marks’ comments echo statements made by former FDA chiefs and public health experts who over the past few days have underscored that vaccine makers are aware...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.